Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...
In this cohort study, midlife hearing loss was linked with smaller brain volumes, faster decline in executive function, and a ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights ...
Explore the alarming rise of early cardiac disease among corporate professionals in India, driven by long hours, stress, and ...
LittleTechGirl on MSN
Women Breaking Barriers and Setting New Standards
Across industries, women continue to challenge expectations and open doors for those who follow. These leaders are bre ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Fisher ARCHitecture turns history into a design advantage, rather than a limitation. The firm breathes new life into older ...
Analysis of Patients from CLEAR Outcomes Receiving No Other Background Lipid Lowering Therapies, Bempedoic Acid Alone Reduced MACE-4 by 14% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback